Austria vs Belgium: The number of people with susceptibility test result for rifampicin
Austria
86.84
in 2021
Belgium
86.27
in 2021
Austria rank
80th
Belgium rank
81st
The number of people with susceptibility test result for rifampicin over time
- Austria
- Belgium
How they compare
Austria currently reports 86.84 against 86.27 in Belgium, a difference of 0.57.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Belgium ahead.
Austria ranks 80th and Belgium ranks 81st of 146 countries.
Across the 2 decades both report, Austria averaged higher in 1 and Belgium in 1.
Head to head by decade
| Decade | Austria | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.78 | 89.93 | 1.14 | Belgium |
| 2020s | 86.89 | 86.15 | 0.7427 | Austria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Belgium?
- Austria, at 86.84 against 86.27 in Belgium as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Belgium?
- 0.57, with Austria ahead.
- How many years of comparable data are there for Austria and Belgium?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Belgium rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 80th and Belgium ranks 81st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.